Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
16
DNUT Quote, Financials, Valuation and Earnings
Last price:
$5.72
Seasonality move
:
0.2%
Day range:
$5.34 - $5.51
52-week range:
$5.31 - $17.84
Dividend yield:
2.59%
P/E ratio:
270.50x
P/S ratio:
0.55x
P/B ratio:
0.81x
Volume:
2M
Avg. volume:
3.8M
1-year change:
-54.42%
Market cap:
$921.3M
Revenue:
$1.7B
EPS (TTM):
$0.02
Krispy Kreme Number of Institutional Trades
Krispy Kreme Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$1.5B
(Last 6 Months)
Current Institutional Ownership Percentage
76.8%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$942.2M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Krispy Kreme Institutional Ownership
-
What Percentage Of DNUT Is Owned by Institutions?
76.8% of DNUT is owned by institutions.
-
How Many Institutions Own DNUT Shares?
Krispy Kreme stock is owned by 335 institutional shareholders at this time.
-
Have Institutions Been Buying DNUT Stock?
Yes, institutions have bought 103.7M shares of DNUT in the last quarter.
-
Have Institutions Been Selling DNUT Stock?
Yes, institutions have sold 52.6M shares of DNUT over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
